Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Microglia and oligodendrocytes
- Microglia
- Development of microglia
- Embryonic microglia
- Adult microglia
- Activated microglia
- Microglial processes monitor the environment
- Pathological signals activate microglia
- Roles of purine receptors in microglial activation
- Microglia and pathogenic pain
- Oligodendrocytes
- Degeneration
- Peripheral nervous system (PNS) degeneration
- Schwann cells (SC) in PNS injury
- Central nervous system (CNS) degeneration
- Nogo is a major myelin inhibitory molecule
- Myelin contains multiple axon growth inhibitors
- Myelin proteins inhibit axon growth - mechanisms
- Oligodendrocyte precursor cells (NG2-glia)
- Demyelination
- Multiple Sclerosis (MS) involves all glial cell types
- Diverse factors involved in MS
- Glutamate is cytotoxic for oligodendrocytes
- Ischemic cell death in immature oligodendrocytes
- ATP acting on P2X7 receptors in demyelination
- MS is characterised by white matter lesions
- Relapse remitting MS
- Acute phase of MS
- Active lesions in MS
- Remyelination in MS
- Neurodegeneration in MS
- Chronic (inactive) MS lesions
- Why does remyelination ultimately fail in MS?
- Conclusions
Topics Covered
- Microglia
- Oligodendrocytes
- Degeneration
- SC in PNS injury
- CNS degeneration
- Mechanisms of axon growth inhibition by myelin proteins
- Oligodendrocyte precursor cells (NG2-glia)
- Demyelination
- Multiple sclerosis
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Butt, A.M. (2011, July 19). Neuropathology of microglia and oligodendrocytes [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/DRTN3018.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Arthur M. Butt has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.